Why So Many on BP Meds Still Miss Target - Top-Institutions - MDSpire

Why So Many on BP Meds Still Miss Target

Most U.S. adults with hypertension missed blood pressure targets—including those on treatment—highlighting gaps in initiation and intensification of therapy, new JAMA data show.

  • By

  • Kathryn Wighton

  • February 2, 2026

  • 3 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Hypertension
    • Epidemiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Hypertension
    • Nephrology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Hypertension
    • Preventive Medicine

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Hypertension
    • Clinical Research

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Hypertension
    • Public Health

Original Source(s)

Why So Many on BP Meds Still Miss Target

  • by Kathryn Wighton

  • February 2, 2026

Related Content

Cardiac intimal sarcoma presenting as basilar artery occlusion treated with tenecteplase and thrombectomy: a case report

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.